Solstein Capital, LLC Bristol Myers Squibb CO Transaction History

Solstein Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 22, 2024	SELL	$48.48 - $57.85 $7,611 - $9,082	-157 Closed	0 $0
Q2 2023 Jul 27, 2023	BUY	$63.71 - $70.74 $10,002 - $11,106	157 New	157 $10,000
Q4 2021 Jan 27, 2022	SELL	$53.63 - $62.52 $24,133 - $28,134	-450 Reduced 26.63%	1,240 $77,000
Q2 2021 Aug 12, 2021	BUY	$61.91 - $67.42 $27,859 - $30,339	450 Added 36.29%	1,690 $113,000
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $73,581 - $82,757	1,240 New	1,240 $78,000
Q4 2020 Feb 11, 2021	SELL	$57.74 - $65.43 $71,597 - $81,133	-1,240 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$46.4 - $67.43 $20,601 - $29,938	444 Added 55.78%	1,240 $69,000
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $39,171 - $51,095	796 New	796 $51,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Solstein Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Solstein Capital, LLC with notifications on news.